Table 2
Relation between p53 expression and clinicopathological features in a series of 27 small intestinal adenocarcinomas
| p53+ (n = 14) | p53− (n = 13) | p Value | |
|---|---|---|---|
| *Only 24 tumours were considered for tumour site. | |||
| Site* | NS | ||
| Duodenum | 4 (33.3%) | 6 (50%) | |
| Jejunum | 5 (41.7%) | 3 (25%) | |
| Ileum | 3 (25%) | 3 (25%) | |
| T stage | NS | ||
| T1 | 0 | 1 (7.7%) | |
| T2 | 0 | 1 (7.7%) | |
| T3 | 10 (71.4%) | 5 (38.5%) | |
| T4 | 4 (28.6%) | 6 (46.1%) | |
| N stage | NS | ||
| N0 | 6 (42.9%) | 2 (15.4%) | |
| N1 | 8 (57.1%) | 11 (84.6%) | |
| No Crohn’s disease | 11 (78.6%) | 12 (92.3%) | NS |
| Crohn’s disease | 3 (21.4%) | 1 (7.7%) | |
